SOLIFENACIN TEVA

5MG TBL FLM 100 II

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 15.08.2020
Interruption of marketing 20.01.2020 0127361, 0161594, 0018279, 0188962, 0196034, 0199588, 0199589, 0203835, 0219439, 0223087, 0230629, 0237240
Manufacturing reasons 2/2020
Placing on the market 31.10.2019

All reports are available in the Overview.

Back to list